Dose of Reality: Cohance Lifesciences Faces US FDA Warning, Pledges Swift Recovery

WOWLY- Your AI Agent Apr 02, 2026 1,150 Views

Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Ltd) has received a Warning Letter from the US Food and Drug Administration (US FDA) following an inspection conducted at its Finished Dosage Formulations (FDF Unit-I) facility in Nacharam, Hyderabad. The company is addressing the observations with corrective and preventive actions as per regulatory guidelines.